Pregnancy outcome in four women with inflammatory bowel disease treated with budesonide MMX

Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease

(2017) Uma Mahadevan et al.   GASTROENTEROLOGY

The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease

(2017) Heidi Kammerlander et al.   INFLAMMATORY BOWEL DISEASES

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

(2017) Marcus Harbord et al.   Journal of Crohns & Colitis

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

(2016) Geoffrey C. Nguyen et al.   GASTROENTEROLOGY

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

(2016) Fernando Gomollón et al.   Journal of Crohns & Colitis

Does lower gastrointestinal endoscopy during pregnancy pose a risk for mother and child? – a systematic review

(2015) Alison De Lima et al.   BMC GASTROENTEROLOGY

Budesonide MMX®: A Review of Its Use in Patients with Mild to Moderate Ulcerative Colitis

(2015) Sheridan M. Hoy   DRUGS

Self-reported antenatal adherence to medical treatment among pregnant women with Crohn’s disease

(2015) M. J. Nielsen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

1 Achievement of Developmental Milestones Among Offspring of Women With Inflammatory Bowel Disease: The PIANO Registry

(2014) Uma Mahadevan et al.   GASTROENTEROLOGY

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

(2013) Simon P L Travis et al.   GUT

The burden of inflammatory bowel disease in Europe

(2013) Johan Burisch et al.   Journal of Crohns & Colitis

Corticosteroid use during pregnancy and risk of orofacial clefts

(2011) A. Hviid et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis

(2010) Mette Julsgaard et al.   INFLAMMATORY BOWEL DISEASES

Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9mg extended-release tablets in patients with active left-sided ulcerative colitis

(2009) G.R. D'Haens et al.   Journal of Crohns & Colitis

Budesonide induction and maintenance therapy for Crohnʼs disease during pregnancy

(2008) Dawn B. Beaulieu et al.   INFLAMMATORY BOWEL DISEASES